Synergistic Effects of EMPs and PMPs on Pulmonary Vascular Leakage and Lung Injury After Ischemia/reperfusion
Overview
Cell Biology
Authors
Affiliations
Background: Vascular leakage is an important pathophysiological process of critical conditions such as shock and ischemia-reperfusion (I/R)-induced lung injury. Microparticles (MPs), including endothelial cell-derived microparticles (EMPs), platelet-derived microparticles (PMPs) and leukocyte-derived microparticles (LMPs), have been shown to participate in many diseases. Whether and which of these MPs take part in pulmonary vascular leakage and lung injury after I/R and whether these MPs have synergistic effect and the underlying mechanism are not known.
Methods: Using hemorrhage/transfusion (Hemo/Trans) and aorta abdominalis occlusion-induced I/R rat models, the role of EMPs, PMPs and LMPs and the mechanisms in pulmonary vascular leakage and lung injury were observed.
Results: The concentrations of EMPs, PMPs and LMPs were significantly increased after I/R. Intravenous administration of EMPs and PMPs but not LMPs induced pulmonary vascular leakage and lung injury. Furthermore, EMPs induced pulmonary sequestration of platelets and promoted more PMPs production, and played a synergistic effect on pulmonary vascular leakage. MiR-1, miR-155 and miR-542 in EMPs, and miR-126 and miR-29 in PMPs, were significantly increased after hypoxia/reoxygenation (H/R). Of which, inhibition of miR-155 in EMPs and miR-126 in PMPs alleviated the detrimental effects of EMPs and PMPs on vascular barrier function and lung injury. Overexpression of miR-155 in EMPs down-regulated the expression of tight junction related proteins such as ZO-1 and claudin-5, while overexpression of miR-126 up-regulated the expression of caveolin-1 (Cav-1), the trans-cellular transportation related protein such as caveolin-1 (Cav-1). Inhibiting EMPs and PMPs production with blebbistatin (BLE) and amitriptyline (AMI) alleviated I/R induced pulmonary vascular leakage and lung injury.
Conclusions: EMPs and PMPs contribute to the pulmonary vascular leakage and lung injury after I/R. EMPs mediate pulmonary sequestration of platelets, producing more PMPs to play synergistic effect. Mechanically, EMPs carrying miR-155 that down-regulates ZO-1 and claudin-5 and PMPs carrying miR-126 that up-regulates Cav-1, synergistically mediate pulmonary vascular leakage and lung injury after I/R. Video Abstract.
Wang Q, Tong Q, Jiang Z, Tang B J Cardiothorac Surg. 2024; 19(1):572.
PMID: 39354590 PMC: 11443705. DOI: 10.1186/s13019-024-03079-x.
The role and mechanisms of microvascular damage in the ischemic myocardium.
Zhao B, Ruze A, Zhao L, Li Q, Tang J, Xiefukaiti N Cell Mol Life Sci. 2023; 80(11):341.
PMID: 37898977 PMC: 11073328. DOI: 10.1007/s00018-023-04998-z.
Yuan H, Liang K, Chen C, Li Y, Liu X, Chen Y Front Cardiovasc Med. 2022; 9:893609.
PMID: 35571221 PMC: 9098995. DOI: 10.3389/fcvm.2022.893609.
Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension.
He Y, Xie X, Zhang H, Ye J, Gencer S, van der Vorst E Front Pharmacol. 2021; 12:753727.
PMID: 34803695 PMC: 8602807. DOI: 10.3389/fphar.2021.753727.
Ding Y, Tu P, Chen Y, Huang Y, Pan X, Chen W Respir Res. 2021; 22(1):291.
PMID: 34774051 PMC: 8590292. DOI: 10.1186/s12931-021-01891-w.